Therapy News and Research

RSS

New technique allows partial-match cell transplants for children with most resistant leukemia

Clinicians at St. Jude Children's Research Hospital have successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia.

16 Oct 2006

Judge declares mistrial in case against Wyeth's Prempro

A judge in a Pennsylvania state court in Philadelphia on Wednesday declared a mistrial in a case in which a jury ruled that the use of Wyeth's combination hormone replacement therapy Prempro in part caused breast cancer to develop in a 66-year-old woman, the Wall Street Journal reports.

16 Oct 2006

Roche asks European Medicines Agency for authorization to market Herceptin

Roche on Friday announced it has submitted an application with the European Medicines Agency to market its breast cancer drug Herceptin as a treatment for women living with an aggressive form of advanced-stage breast cancer, called HER2-positive, and hormone receptor-positive breast cancer, AFX/Forbes reports (AFX/Forbes, 10/13).

16 Oct 2006

Drug therapy for heroin addicts helps women quit smoking

New research is suggesting that women trying to quit smoking can be helped by taking medication approved for the treatment of alcohol and heroin dependence.

10 Oct 2006

Nanoparticle encapsulation improves bioavailability of leukemia drug

Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.

9 Oct 2006

California agency releases 10-year plan for spending $3B on embryonic stem cell research

The California Institute for Regenerative Medicine -- which is in charge of implementing the 10-year, $2.95 billion state human embryonic stem cell research program approved under Proposition 71 -- on Wednesday released a draft spending plan that "sets a strikingly modest tone" for outcomes of the research.

5 Oct 2006

FDA approves test to help diagnose HIV

The U.S. Food and Drug Administration (FDA) has approved the APTIMA HIV-1 RNA Qualitative Assay, manufactured by Gen-Probe Incorporated (San Diego, Calif.).

5 Oct 2006

New drug a breakthrough in the treatment of AMD

Age-related macular degeneration (AMD), is a common cause of vision loss and often affects older people.

5 Oct 2006

Advanced Neuromodulation Systems receives Australian approval for rechargeable chronic pain system

Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc, today announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon Rechargeable Neurostimulation System.

3 Oct 2006

Super chow, laced with semi-synthetic vitamin E derivative, inhibited spread of cancer in mice

A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.

2 Oct 2006

Men as likely as women to shop 'til they drop

According to psychologists in the U.S. men are just as likely to be shopaholics as women.

2 Oct 2006

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer

Investigators developing an inhalable nanoparticle for treating lung cancer have shown that a surface molecule found on malignant lung cells can serve as an effective target for improving drug delivery.

25 Sep 2006

Black people with bladder cancer more likely to die of the disease than white

Black patients with bladder cancer are 35 percent more likely to die of the disease than white patients, according to a new study from the University of Michigan Comprehensive Cancer Center.

21 Sep 2006

New target for cancer therapy identified by Australian researchers

A new target for cancer therapy has been identified by Monash University scientists investigating the cell signalling pathways that turn on a gene involved in cancer development.

21 Sep 2006

Leptin could combat type 2 diabetes

University of Florida researchers have discovered the appetite-controlling hormone leptin could also combat type 2 diabetes, a disease that has become a growing problem in the United States as more Americans pack on extra pounds.

21 Sep 2006

How the brain resolves emotional conflict

Daily life requires that people cope with distracting emotions--from the basketball player who must make a crucial shot amidst a screaming crowd, to a salesman under pressure delivering an important pitch to a client.

21 Sep 2006

WHO backs health sector response to HIV pandemic

The World Health Organization Western Pacific Region, in collaboration with international partner agencies, is seeking to scale up HIV/AIDS prevention and control activities in line with the goal of universal access for HIV/AIDS treatment throughout Asia and the Pacific by 2010.

21 Sep 2006

Carbon monoxide shown to reverse symptoms of pulmonary hypertension

In a medical case of Jekyll and Hyde, carbon monoxide - the highly toxic gas emitted from auto exhausts and faulty heating systems - has proven effective in treating the symptoms of pulmonary arterial hypertension (PAH), an extremely debilitating condition that typically leads to right heart failure and eventual death.

20 Sep 2006

GSK seeks regulatory approval in U.S., Europe for Tykerb

GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of this year, Reuters reports.

20 Sep 2006

Use of unapproved drugs in the U.S.

USA Today on Monday looked at the use of unapproved drugs in the U.S., including some that are used to treat menopause symptoms (Rubin, USA Today, 9/18).

20 Sep 2006